Bovine Serum Albumin Market Size, Share, Growth, Trends, and Forecast - 2025

The report "Bovine Serum Albumin Market by Form (Dry, Liquid), Grade (Technical-& Diagnostic-Grade, Research/Reagent-Grade, Food Grade), End User (Life Sciences Industry, Feed Industry, Food Industry, Research Institutes), and Region - Global Forecast to 2025", is estimated to be valued at USD 255 million in 2019 and is projected to reach a value of USD 304 million by 2025, growing at a CAGR of 3.0% during the forecast period. Factors such as the inexpensive and stable nature of bovine serum albumin as a protein standard, growing demand for blood-based products are some of the factors driving the growth of the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20219222

By end user, the life sciences segment is projected to be the fastest-growing segment in the market for bovine serum albumin during the forecast period.

The life sciences segment in the market is projected to be the fastest-growing segment, as extensive research is being conducted in the pharmaceutical and biotechnology industries. Also, bovine serum albumin is used in the production of vaccines, drug delivery, and preparation of mammalian cell culture media. Due to the advancements in nanotechnology, drug delivery, as an application, is growing rapidly in the life sciences segment.

By form, the dry form segment is projected to dominate the market during the forecast period.

The dry form segment is projected to hold the largest market share in the bovine serum market during the forecast period. The dry form of bovine serum albumin is mostly preferred over the liquid form by manufacturers because of its longer shelf life. This attribute of the dry form has also led to the rise in imports and exports of bovine serum albumin

By grade, the technical- & diagnostic-grade segment is projected to dominate the market for bovine serum albumin during the forecast period.

The technical- & diagnostic-grade segment dominates the bovine serum albumin market due to the growing demand for vaccines and owing to the large application areas varying between cell culture, assay kit preparations, and serving as protein standards. The technical- & diagnostic-grade of BSA is most recommended for biotechnology applications such as immunodetections as a blocking and saturating agent. Most products that belong to this grade are used in cell culture applications.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=20219222

The Asia Pacific region is projected to grow at the highest CAGR during the forecast period

The Asia Pacific region holds a range of opportunities for pharmaceutical firms and multinational drugmakers. In the Asia Pacific region, China is the largest market for pharmaceutical products. With the growing interest in health and welfare, the demand for pharmaceutical products is growing. This would help drive the growth of BSA in this region.

This report includes a study on the marketing and development strategies, along with a study on the product portfolios of the leading companies operating in the bovine serum albumin market. It includes the profiles of leading companies such as Thermo Fisher Scientific (US), Bio-Rad Laboratories, Inc (US), Merck KGAA (Germany), Itoham Yonekyu Holdings Inc (Japan), Proliant Biologicals (US), Kraeber & Co Gmbh (Germany), Rockland Immunochemicals Inc (US), Rocky mountain biologicals (US), BelHealth investment partners, LLC (US), Bio-Techne Corporation (US), Prospec-Tany Technogene Ltd (Israel), LGC Group (UK), Promega Corporation (US), Biological Industries (Israel), and Serion GmbH (Germany).

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.